Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-04

Clinical Trial Update: Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ETC-1002 in people with high cholesterol and high blood pressure has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ETC-1002 (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-04-04